Limes Schlosskliniken AG Net Assets
Limes Schlosskliniken AG net assets. Based on the latest financial reports, Limes Schlosskliniken AG (LIK) has net assets worth €25.85 Million EUR (≈ $30.22 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€43.45 Million ≈ $50.80 Million USD) and total liabilities (€17.61 Million ≈ $20.58 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how fast is Limes Schlosskliniken AG growing its equity to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €25.85 Million |
| % of Total Assets | 59.49% |
| Annual Growth Rate | 18.25% |
| 5-Year Change | 325.16% |
| 10-Year Change | N/A |
| Growth Volatility | 55.87 |
Net Assets of Limes Schlosskliniken AG (2017–2025)
Net assets of Limes Schlosskliniken AG from 2017 to 2025. This chart illustrates how Limes Schlosskliniken AG's net assets have evolved over time, based on quarterly financial data. See Limes Schlosskliniken AG balance sheet independence to measure how much of total assets are equity-financed.
Annual Net Assets for Limes Schlosskliniken AG (2017–2025)
The table below shows the annual net assets of Limes Schlosskliniken AG from 2017 to 2025. For live market cap and overall valuation, see LIK company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €26.83 Million ≈ $31.36 Million |
+35.18% |
| 2024-12-31 | €19.84 Million ≈ $23.20 Million |
+19.23% |
| 2023-12-31 | €16.64 Million ≈ $19.46 Million |
+48.65% |
| 2022-12-31 | €11.20 Million ≈ $13.09 Million |
+77.45% |
| 2021-12-31 | €6.31 Million ≈ $7.38 Million |
+135.49% |
| 2020-12-31 | €2.68 Million ≈ $3.13 Million |
-20.58% |
| 2019-12-31 | €3.37 Million ≈ $3.94 Million |
-62.74% |
| 2018-12-31 | €9.05 Million ≈ $10.59 Million |
+29.03% |
| 2017-12-31 | €7.02 Million ≈ $8.20 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Limes Schlosskliniken AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1672958700.0% over the analyzed period, indicating profitable operations and earnings retention.
Limes Schlosskliniken AG Net Assets Breakdown (December 2025)
Limes Schlosskliniken AG net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €14.70 Million | 58.09% |
| Common Stock | €297.95K | 1.18% |
| Other Components | €10.31 Million | 40.73% |
| Total Equity | €25.31 Million | 100.00% |
Limes Schlosskliniken AG Competitors by Market Cap
The table below lists competitors of Limes Schlosskliniken AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Partron Co. Ltd
KQ:091700
|
$159.46 Million |
|
Suryoday Small Finance Bank Limited
NSE:SURYODAY
|
$159.49 Million |
|
QuasarEdge Acquisition Corporation
NYSE:QRED
|
$159.52 Million |
|
Red Robin Gourmet Burgers Inc
NASDAQ:RRGB
|
$159.55 Million |
|
Sahamitr Pressure Container Public Company Limited
BK:SMPC
|
$159.40 Million |
|
Nordfyns Bank A/S
CO:NRDF
|
$159.36 Million |
|
Smec Co.Ltd
KQ:099440
|
$159.36 Million |
|
GalaxyEdge Acquisition Corporation
NYSE:GLED
|
$159.35 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Limes Schlosskliniken AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 18,329,824 to 25,311,430, a change of 6,981,606 (38.1%).
- Net income of 5,694,977 contributed positively to equity growth.
- Share repurchases of 57,320 reduced equity.
- Other factors increased equity by 1,343,949.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €5.69 Million | +22.5% |
| Share Repurchases | €57.32K | -0.23% |
| Other Changes | €1.34 Million | +5.31% |
| Total Change | €- | 38.09% |
Book Value vs Market Value Analysis
This analysis compares Limes Schlosskliniken AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.18x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €-6.47 | €525.00 | x |
| 2018-12-31 | €-11.56 | €525.00 | x |
| 2019-12-31 | €11.51 | €525.00 | x |
| 2020-12-31 | €9.14 | €525.00 | x |
| 2021-12-31 | €21.52 | €525.00 | x |
| 2022-12-31 | €37.86 | €525.00 | x |
| 2023-12-31 | €51.60 | €525.00 | x |
| 2024-12-31 | €62.52 | €525.00 | x |
| 2025-12-31 | €84.95 | €525.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Limes Schlosskliniken AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 22.50%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.39%
- • Asset Turnover: 1.11x
- • Equity Multiplier: 1.78x
- Recent ROE (22.50%) is above the historical average (12.44%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 0.00% | -19.17% | 0.67x | 0.00x | €-1.07 Million |
| 2018 | 0.00% | -19.32% | 0.79x | 0.00x | €-1.14 Million |
| 2019 | -24.45% | -10.08% | 0.86x | 2.82x | €-1.16 Million |
| 2020 | -25.92% | -6.30% | 0.93x | 4.40x | €-962.35K |
| 2021 | 62.51% | 16.83% | 1.27x | 2.92x | €3.31 Million |
| 2022 | 37.87% | 14.59% | 1.08x | 2.40x | €3.09 Million |
| 2023 | 22.45% | 9.14% | 1.12x | 2.20x | €1.88 Million |
| 2024 | 16.98% | 8.31% | 0.97x | 2.10x | €1.28 Million |
| 2025 | 22.50% | 11.39% | 1.11x | 1.78x | €3.16 Million |
Industry Comparison
This section compares Limes Schlosskliniken AG's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $5,069,297,185
- Average return on equity (ROE) among peers: 1.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Limes Schlosskliniken AG (LIK) | €25.85 Million | 0.00% | 0.68x | $159.40 Million |
| China Resources Medical Holdings Company Limited (1PH) | $6.85 Billion | 6.10% | 0.53x | $354.05 Million |
| AEST.MED.INT.HLD.SP.ADR/3 (3FMA) | $-186.42 Million | 0.00% | 0.00x | $3.30 Million |
| JINXIN FERT.GRP HD-00001 (3NX) | $8.74 Billion | 1.39% | 0.74x | $582.53 Million |
| REVITALIST L.A.W. LTD (4DO) | $-11.05 Million | 0.00% | 0.00x | $744.60K |
| Wenzhou Kangning Hospital Co. Ltd (4WK) | $1.26 Billion | 4.54% | 0.68x | $24.75 Million |
| HYGEIA HC HLDGS DL-00001 (50I) | $4.48 Billion | 9.86% | 0.49x | $11.74K |
| COMPASS PATHW SP.ADR (5Y6) | $284.41 Million | -25.22% | 0.06x | $657.30 Million |
| Bumrungrad Hospital Public Company Limited (BZ7A) | $27.80 Billion | 27.97% | 0.17x | $56.99K |
| GUANGDONG KANG.CO.LTD YC1 (E9Q) | $1.47 Billion | 6.40% | 0.83x | $17.17 Million |
| Eifelhöhen-Klinik AG (EIF) | $9.88 Million | -19.11% | 6.64x | $10.05 Million |
About Limes Schlosskliniken AG
LIMES Schlosskliniken AG operates private clinics for psychiatry, psychotherapy, and psychosomatics services in Germany, Switzerland, Italy, and Liechtenstein. The company focuses on the treatment of stress-related illnesses; and mental and psychological disorders, such as depression, acute burnout, affective disorders, trauma/PTSD, anxiety disorders, attention deficit hyperactivity disorder, per… Read more